The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer
Official Title: Breast Cancer Biomarkers Based on Fine Needle Aspirates
Study ID: NCT00041353
Brief Summary: RATIONALE: Examining biomarkers in fine-needle aspiration specimens from women at risk for breast cancer may improve the ability to detect breast cancer cells early and plan effective treatment. PURPOSE: Screening trial to compare specific biomarkers based on fine-needle aspiration specimens from women at increased or normal risk of breast cancer.
Detailed Description: OBJECTIVES: * Compare specific biomarkers, including cellular morphology (cytology), proliferation index (Ki-67), p53 expression, and LOH in chromosome 9p at locus DS9157, in fine needle aspirate specimens from women at increased vs normal risk of breast cancer. * Determine whether these specimens are adequate to perform the biomarker assays and whether this technique could be used in the general outpatient setting. * Determine whether biomarker levels in these patients are concordant or discordant with individual clinical risk of breast cancer. * Determine whether 1 or more biomarkers can distinguish high-risk from control patients. * Correlate specific biomarkers and changes in biomarker levels with pathologic diagnosis from the breast biopsy. OUTLINE: Patients undergo fine needle aspiration of normal appearing breast tissue prior to the beginning of elective surgery. Specimens are analyzed for the presence of specific biomarkers. PROJECTED ACCRUAL: Approximately 156 patients will be accrued for this study within 3 years.
Minimum Age: 30 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Name: Michael H. Torosian, MD
Affiliation: Fox Chase Cancer Center
Role: STUDY_CHAIR